(Total Views: 375)
Posted On: 05/10/2017 10:40:26 PM
Post# of 9144
Would like to hear how the gbs n assay is coming along with Faro. The one where they won an award for.
Being positive, on the ihub board a poster applies some metrics to the outstanding shares and revenue it will take to warrant a .07 stock price. 1 million a yearin revenue he says. That seems very attainable short to slight mid term. If they get to 1 million revenue, with the n assay, they could and should go much higher in revenue. 5 million only commands a .35 cent per share price. They get to five mil, the forward looking PE is going to go nuts and the price could soar with some proper transparency. More news has becoming out recently and most of it is good.
Being positive, on the ihub board a poster applies some metrics to the outstanding shares and revenue it will take to warrant a .07 stock price. 1 million a yearin revenue he says. That seems very attainable short to slight mid term. If they get to 1 million revenue, with the n assay, they could and should go much higher in revenue. 5 million only commands a .35 cent per share price. They get to five mil, the forward looking PE is going to go nuts and the price could soar with some proper transparency. More news has becoming out recently and most of it is good.
(3)
(0)
